EUVIMEDEUVIMED entdecken
FallberichtOpen Access

First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report

Camilla O Hoff iD, Eduardo Andreazza Dal Lago iD, Juliana Mota Siqueira iD, Luana G de Sousa iD, Adel K El-Naggar, Jordi Rodon Ahnert iD, Renata Ferrarotto iD

JCO Precision Oncology · 2024-04 · (8)

DOI: 10.1200/po.23.00633 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCO Precision Oncology, 2024-04. Verfasst von Camilla O Hoff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Axl Receptor Tyrosine Kinase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

First use of AXL-targeting in adenoid cystic carcinoma (ACC); with positive results, ACC now included in AXL studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Adenoid CysticAxl Receptor Tyrosine KinaseHumans

Substanzen

AXL protein, humanAxl Receptor Tyrosine Kinase

Autor:innen und Institutionen

  • Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.

ORCID-Profile: Camilla O Hoff, Eduardo Andreazza Dal Lago, Juliana Mota Siqueira, Luana G de Sousa, Jordi Rodon Ahnert, Renata Ferrarotto

Förderung

  • NIDCR NIH HHS

Zitieren

APA

Hoff, C. O., Dal Lago, E. A., Siqueira, J. M., de Sousa, L. G., El-Naggar, A. K., Ahnert, J. R., & Ferrarotto, R. (2024). First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report. JCO Precision Oncology. https://doi.org/10.1200/po.23.00633

Vancouver

Hoff CO, Dal Lago EA, Siqueira JM, de Sousa LG, El-Naggar AK, Ahnert JR, et al. First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report. JCO Precision Oncology. 2024. doi:10.1200/po.23.00633

BibTeX
@article{Hoff2024,
  author = {Hoff, Camilla O and Dal Lago, Eduardo Andreazza and Siqueira, Juliana Mota and de Sousa, Luana G and El-Naggar, Adel K and Ahnert, Jordi Rodon and Ferrarotto, Renata},
  title = {First Use of AXL Targeting in Metastatic, Refractory, Adenoid Cystic Carcinoma: A Case Report},
  journal = {JCO Precision Oncology},
  year = {2024},
  number = {8},
  doi = {10.1200/po.23.00633}
}
Kostenlos starten →